Clinical Trial Update: Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of BETOPTIC S 0.25% and Timolol Gel-forming Solution at 0.25% and 0.5% in pediatric glaucoma or ocular hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• BETOPTIC S 0.25% (betaxolol)
• Timolol Gel-forming Solution 0.25% (timolol)
• Timolol Gel-forming Solution 0.5% (timolol)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED